Brianna Allain
Internal Medicine · Elmhurst, NYNPI 1578224119
Payments from drug & device makers
Across 255 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$688
- AbbVie$605
- Sanofi$594
- Dermavant Sciences, Inc.$497
- Arcutis Biotherapeutics, Inc.$314
- Novartis$309
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,28297%
- Education$1723%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $688 |
| AbbVie | 26 | $605 |
| Sanofi | 20 | $594 |
| Dermavant Sciences, Inc. | 16 | $497 |
| Arcutis Biotherapeutics, Inc. | 24 | $314 |
| Novartis | 16 | $309 |
| E.r. Squibb & Sons, L.L.C. | 17 | $304 |
| Incyte Corporation | 28 | $302 |
| Lilly USA, LLC | 16 | $301 |
| Novo Nordisk | 14 | $291 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $174 |
| Johnson & Johnson | 4 | $158 |
| Sun Pharmaceutical Industries Inc. | 4 | $108 |
| Galderma Laboratories, L.p. | 5 | $96 |
| Sanofi-aventis U.S. LLC | 2 | $93 |
| LEO Pharma Inc. | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Organon | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Amarin Pharma, Inc. | 2 | $47 |
| Intercept Pharmaceuticals, Inc. | 2 | $40 |
| Ardelyx, Inc. | 1 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Redhill Biopharma Inc. | 1 | $25 |
| Mayne Pharma Commercial LLC | 3 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,454 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 16 | $116,192 |
| Triamcinolone Acetonide | 358 | $31,889 |
| Ketoconazole | 259 | $29,441 |
| ErtaczoSertaconazole Nitrate | 12 | $24,721 |
| Hydrocortisone Butyrate | 47 | $24,192 |
| Clindamycin Phosphate | 40 | $18,465 |
| Diflorasone Diacetate | 11 | $11,884 |
| Tretinoin | 62 | $8,711 |
| Tacrolimus | 25 | $6,422 |
| Mometasone Furoate | 151 | $3,681 |
| Calcipotriene | 17 | $3,628 |
| Ciclopirox | 75 | $3,142 |
| Halobetasol Propionate | 36 | $2,652 |
| Ammonium Lactate | 60 | $1,811 |
| Mupirocin | 235 | $1,451 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Elmhurst
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.